Clinical Trials Directory

Trials / Completed

CompletedNCT00138788

Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases

To Determine Which of Two Radiotherapy Brain Fractionation Schemes is Superior in the Treatment of Brain Metastases

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
St George Hospital, Australia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a comparison of radiotherapy fractionation schemes for brain metastasis.

Detailed description

Untreated brain metastases are usually fatal within a few weeks. The standard treatment for brain metastases is whole brain irradiation. This results on average in an increase in survival by 2 to 4 times compared to withholding irradiation. The majority of patients experience improvement in the level of functioning as a result of irradiation. None-the-less approximately half of patients die because of progression of the brain metastases and their quality of life is often dominated by the effects of brain metastases. Various different dosages of radiation have been assessed and we wish to further investigate this by comparing a less intense schema with a more intense schema. Both of these fall within the range of published experience but have not been directly compared. The more intense schema may have more effect on the tumour but previous variations of dose intensity have not shown significant differences in survival. Differences in control of the metastases in the brain have been suggested but there have been no good comparisons of quality of life. Obviously when survival is measured on average in only 3 to 6 months, this is an important parameter for comparison. Comparisons: Stratification is by diagnosis either excision or biopsy/clinical. Patients will be randomised to receive either 40Gy 20#bd or 20Gy 4#daily.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiotherapy, dose fractionation

Timeline

Start date
1996-02-01
Primary completion
2007-03-01
Completion
2007-03-01
First posted
2005-08-30
Last updated
2008-11-20

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00138788. Inclusion in this directory is not an endorsement.